Lincoln Pharmaceuticals Limited (LPL) is engaged in the business of manufacturing, marketing and distribution of pharmaceutical products. The Company operates through the Pharmaceuticals Products segment. The Company offers products, such as tablets, capsules, liquid injection, cream in tubes, dry power injection, liquid in bott, liquid injection and pharma products. It has operations in cardiac, diabetic, anti-malarial, anti-biotics, cephalosporins, analgesic, antipyretics, vitamin-minerals and iron preparations, among others. Its geographical segments include Domestic Sales and Export Sales. Its products include Tinnex, which is a medication for treating cochlear synaptic tinnitus; Pa 12 Proglet, which is a 1000 milligram programmed released paracetamol that is developed to offer control of pain and fever, and ARH 1, which is an anti-malarial drug that is formulated utilizing technology known as dose optimization technology.